Log in

OTCMKTS:RSLSD - ReShape Lifesciences Stock Price, Forecast & News

+0.10 (+1.83 %)
(As of 12/12/2019)
Today's Range
Now: $5.55
50-Day Range
MA: $5.52
52-Week Range
Now: $5.55
Volume637 shs
Average Volume2,180 shs
Market Capitalization$1.94 million
P/E RatioN/A
Dividend YieldN/A
ReShape Lifesciences Inc., a medical device company, focuses on the design, development, and commercialization of technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. The company's product portfolio includes ReShape vBloc, a therapy that enables patients to feel full and eat less by intermittently blocking hunger signals on the vagus nerve; ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without permanently changing patient anatomy; and Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in October 2017. ReShape Lifesciences Inc. was founded in 2002 and is headquartered in San Clemente, California.

Industry, Sector and Symbol

Industry Electromedical equipment



Sales & Book Value

Annual Sales$610,000.00
Cash Flow$69.38 per share
Book Value$341.84 per share


Net Income$-81,150,000.00
Net Margins-668.58%


Market Cap$1.94 million
Next Earnings Date5/21/2020 (Estimated)
OptionableNot Optionable

Receive RSLSD News and Ratings via Email

Sign-up to receive the latest news and ratings for RSLSD and its competitors with MarketBeat's FREE daily newsletter.

ReShape Lifesciences (OTCMKTS:RSLSD) Frequently Asked Questions

What is ReShape Lifesciences' stock symbol?

ReShape Lifesciences trades on the OTCMKTS under the ticker symbol "RSLSD."

When is ReShape Lifesciences' next earnings date?

ReShape Lifesciences is scheduled to release their next quarterly earnings announcement on Thursday, May 21st 2020. View Earnings Estimates for ReShape Lifesciences.

Has ReShape Lifesciences been receiving favorable news coverage?

News stories about RSLSD stock have trended somewhat positive recently, InfoTrie Sentiment reports. The research firm scores the sentiment of media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. ReShape Lifesciences earned a media sentiment score of 1.8 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for ReShape Lifesciences.

Who are some of ReShape Lifesciences' key competitors?

Who are ReShape Lifesciences' key executives?

ReShape Lifesciences' management team includes the folowing people:
  • Mr. Barton P. Bandy, Pres, CEO & Director (Age 58)
  • Dr. Mark B. Knudson, Co-Founder and Special Advisor to the CEO (Age 70)
  • Dr. Katherine S. Tweden Ph.D., Co-Founder (Age 58)
  • Mr. Thomas Stankovich, Chief Financial Officer (Age 58)
  • Mr. Vipul Shah, Sr. VP of Operations and R&D

How do I buy shares of ReShape Lifesciences?

Shares of RSLSD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is ReShape Lifesciences' stock price today?

One share of RSLSD stock can currently be purchased for approximately $5.55.

How big of a company is ReShape Lifesciences?

ReShape Lifesciences has a market capitalization of $1.94 million and generates $610,000.00 in revenue each year. ReShape Lifesciences employs 43 workers across the globe.View Additional Information About ReShape Lifesciences.

What is ReShape Lifesciences' official website?

The official website for ReShape Lifesciences is http://www.reshapelifesciences.com/.

How can I contact ReShape Lifesciences?

ReShape Lifesciences' mailing address is 1001 Calle Amanecer, Clemente CA, 92673. The company can be reached via phone at 949-429-6680 or via email at [email protected]

MarketBeat Community Rating for ReShape Lifesciences (OTCMKTS RSLSD)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  7 (Vote Outperform)
Underperform Votes:  11 (Vote Underperform)
Total Votes:  18
MarketBeat's community ratings are surveys of what our community members think about ReShape Lifesciences and other stocks. Vote "Outperform" if you believe RSLSD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RSLSD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/17/2020 by MarketBeat.com Staff

Featured Article: Correction

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel